Browsing publications by Dr Peter Donaldson

Newcastle AuthorsTitleYear
Professor Heather Cordell
Sam Ducker
Dr Peter Donaldson
Professor David Jones
Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis2012
Professor Heather Cordell
Sam Ducker
Dr Peter Donaldson
Professor David Jones
Dense fine-mapping study identifies novel disease loci and implicates coding and non-coding variation in primary Mary cirrhosis risk2012
Dr Peter Donaldson
Electrostatic modifications of the human leukocyte antigen DR P9 peptide-binding pocket in primary sclerosing cholangitis: Back to the future with human leukocyte antigen DR beta2011
Professor Heather Cordell
Dr Peter Donaldson
Sam Ducker
Professor David Jones
Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis2011
Professor Chris Day
Dr Peter Donaldson
Professor Ann Daly
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and class II alleles2011
Professor Heather Cordell
Dr Peter Donaldson
Professor David Jones
Genome-wide association study identifies more than 10 primary biliary cirrhosis risk loci2010
Dr Peter Donaldson
Professor Ann Daly
Jill Henderson
Professor Chris Day
Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury2010
Professor Heather Cordell
Sam Ducker
Dr Peter Donaldson
Professor David Jones
Validation of the north american genome-wide association study of primary biliary cirrhosis and identification of additional genetic susceptibility loci in a British cohort2010
Professor Ann Daly
Dr Peter Donaldson
Dr Pallav Bhatnagar
Julia Patch
Professor Heather Cordell
et al.
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin2009
Dr David Sheridan
Dr David Price
Dr Matthias Schmid
Professor Geoff Toms
Dr Peter Donaldson
et al.
Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirin2009
1234567891011